PMDA drug package insert
注射用メソトレキセート50mg
PMDA Prescription drug · ファイザー株式会社 · package insert Sep 16, 2026
Key facts
| Brand names | 注射用メソトレキセート50mg |
|---|---|
| Nonproprietary names | メトトレキサート |
| Companies | 製造販売元／ファイザー株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 葉酸代謝拮抗剤 |
| Therapeutic category codes | 874222 |
| YJ codes | 4222400D2020 |
| Approval numbers | 14300AMY00035 |
| Package insert edition | 第5版 |
| Package insert date | Sep 16, 2026 |
| PMDA document key | 672212_4222400D2020_3 |
| PMDA company code | 672212 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: